SPHINGOLIPID METABOLISM'S ALTERATIONS CORRELATED WITH TUMOR CELL INVASIVITY AND FENRETINIDE RESISTANCE IN A HUMAN OVARIAN CARCINOMA CELL LINE
Giuditta Illuzzi(AstraZeneca (Germany))
Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano)
December 9, 2010
Cited by 0
Related Papers
Genetic evidence for PARP1 trapping as a driver of PARP inhibitor efficacy in <i>BRCA</i> mutant cancer cells
|Nucleic Acids Research|2025|2